RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 71 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is 42.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $374,000 | -94.6% | 41,657 | -96.8% | 0.00% | -100.0% |
| Q2 2016 | $6,920,000 | +18.6% | 1,288,685 | +1.6% | 0.01% | +14.3% |
| Q1 2016 | $5,833,000 | -11.9% | 1,268,035 | -0.4% | 0.01% | -12.5% |
| Q4 2015 | $6,620,000 | -13.8% | 1,273,135 | +0.3% | 0.01% | 0.0% |
| Q3 2015 | $7,683,000 | -62.4% | 1,269,835 | -2.0% | 0.01% | -60.0% |
| Q2 2015 | $20,453,000 | +90.0% | 1,295,297 | +30.8% | 0.02% | +100.0% |
| Q1 2015 | $10,763,000 | +3452.1% | 990,197 | +3338.5% | 0.01% | – |
| Q4 2014 | $303,000 | +23.7% | 28,797 | +12.9% | 0.00% | – |
| Q3 2014 | $245,000 | -16.7% | 25,497 | 0.0% | 0.00% | – |
| Q2 2014 | $294,000 | +15.3% | 25,497 | 0.0% | 0.00% | – |
| Q1 2014 | $255,000 | -18.0% | 25,497 | +6.7% | 0.00% | – |
| Q4 2013 | $311,000 | -15.0% | 23,897 | -2.4% | 0.00% | – |
| Q3 2013 | $366,000 | -81.7% | 24,497 | -88.6% | 0.00% | -100.0% |
| Q2 2013 | $2,002,000 | – | 214,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |